title: Neonatal bone abnormalities attributable to maternal administration of magnesium sulphate.
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Tsukahara
authors.forename: Ritsuyo
authors.initials: R
authors.lastname: Kobata
authors.forename: Satoshi
authors.initials: S
authors.lastname: Tamura
authors.forename: Mitsufumi
authors.initials: M
authors.lastname: Mayumi
mesh_terms: D000014:Abnormalities, Drug-Induced; D001842:Bone and Bones / Q000002:abnormalities*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008278:Magnesium Sulfate / Q000008:administration & dosage* / Q000009:adverse effects*; D008297:Male; D011225:Pre-Eclampsia / Q000188:drug therapy; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D015145:Tocolysis / Q000009:adverse effects; D015149:Tocolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D014310:Triplets; D014427:Twins
chemical_list: D015149:Tocolytic Agents; D008278:Magnesium Sulfate